佰仁医疗
(688198)
| 流通市值：141.68亿 | | | 总市值：141.68亿 |
| 流通股本：1.37亿 | | | 总股本：1.37亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 292,324,016.69 | 190,683,312.95 | 76,265,199.91 | 370,638,328.12 |
| 营业收入 | 292,324,016.69 | 190,683,312.95 | 76,265,199.91 | 370,638,328.12 |
| 二、营业总成本 | 245,184,032.93 | 163,454,440.27 | 76,377,849.14 | 270,457,757.53 |
| 营业成本 | 33,427,904.06 | 20,456,064.06 | 8,172,523.24 | 37,638,664.42 |
| 税金及附加 | 2,384,147.13 | 1,761,879.82 | 530,800.66 | 2,108,906.85 |
| 销售费用 | 81,737,233.26 | 53,610,777.11 | 23,598,832.35 | 100,732,858.27 |
| 管理费用 | 22,407,154.06 | 14,903,144.64 | 8,196,499.21 | 31,235,197.3 |
| 研发费用 | 108,992,107.86 | 77,066,518.91 | 40,109,397.09 | 98,812,481.99 |
| 财务费用 | -3,764,513.44 | -4,343,944.27 | -4,230,203.41 | -70,351.3 |
| 其中:利息费用 | 358,594.35 | 241,840.89 | 121,113.23 | 414,739.89 |
| 其中:利息收入 | 4,789,476.85 | 4,681,567.75 | 4,402,041.43 | 786,658.69 |
| 加:公允价值变动收益 | 643,981.26 | 313,887.64 | 418,590.33 | 999,386.3 |
| 加:投资收益 | 7,632,128.6 | 5,553,541.83 | 2,803,910.07 | 16,874,958.19 |
| 资产处置收益 | 149.61 | - | - | 56,582.61 |
| 信用减值损失(新) | -612,526.8 | -283,060.28 | 38,448.78 | -1,485,484.16 |
| 其他收益 | 4,366,528.65 | 2,387,716.13 | 2,127,552.96 | 4,193,114.63 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 59,170,245.08 | 35,200,958 | 5,275,852.91 | 120,819,128.16 |
| 加:营业外收入 | 46,436.46 | 44,332.35 | 36,144.05 | 306,987.84 |
| 减:营业外支出 | 2,170,714.35 | 631,069.86 | 500,335.66 | 1,108,778.26 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 57,045,967.19 | 34,614,220.49 | 4,811,661.3 | 120,017,337.74 |
| 减:所得税费用 | 7,040,113.52 | 6,564,468.78 | 915,400.85 | 10,608,511.9 |
| 六、净利润 | 50,005,853.67 | 28,049,751.71 | 3,896,260.45 | 109,408,825.84 |
| 持续经营净利润 | 50,005,853.67 | 28,049,751.71 | 3,896,260.45 | 109,408,825.84 |
| 归属于母公司股东的净利润 | 58,693,362.23 | 35,190,693.59 | 8,319,805.58 | 115,206,553.74 |
| 少数股东损益 | -8,687,508.56 | -7,140,941.88 | -4,423,545.13 | -5,797,727.9 |
| (一)基本每股收益 | 0.43 | 0.26 | 0.06 | 0.85 |
| (二)稀释每股收益 | 0.43 | 0.26 | 0.06 | 0.84 |
| 八、其他综合收益 | -296,622.83 | 262,581.93 | 1,391,822.86 | 1,285,985.48 |
| 归属于母公司股东的其他综合收益 | -296,622.83 | 262,581.93 | 1,391,822.86 | 1,285,985.48 |
| 九、综合收益总额 | 49,709,230.84 | 28,312,333.64 | 5,288,083.31 | 110,694,811.32 |
| 归属于母公司股东的综合收益总额 | 58,396,739.4 | 35,453,275.52 | 9,711,628.44 | 116,492,539.22 |
| 归属于少数股东的综合收益总额 | -8,687,508.56 | -7,140,941.88 | -4,423,545.13 | -5,797,727.9 |
| 公告日期 | 2024-10-30 | 2024-08-22 | 2024-04-23 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |